270 related articles for article (PubMed ID: 29915065)
1. Timing of DNA damage responses impacts persistence to fluoroquinolones.
Mok WWK; Brynildsen MP
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6301-E6309. PubMed ID: 29915065
[TBL] [Abstract][Full Text] [Related]
2. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
Völzing KG; Brynildsen MP
mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
[TBL] [Abstract][Full Text] [Related]
3. RNA Futile Cycling in Model Persisters Derived from MazF Accumulation.
Mok WW; Park JO; Rabinowitz JD; Brynildsen MP
mBio; 2015 Nov; 6(6):e01588-15. PubMed ID: 26578677
[TBL] [Abstract][Full Text] [Related]
4. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones.
Lemma AS; Brynildsen MP
mBio; 2021 Aug; 12(4):e0198321. PubMed ID: 34399616
[TBL] [Abstract][Full Text] [Related]
5. Single-cell imaging and characterization of
Goormaghtigh F; Van Melderen L
Sci Adv; 2019 Jun; 5(6):eaav9462. PubMed ID: 31223653
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
Barrett TC; Mok WWK; Murawski AM; Brynildsen MP
Nat Commun; 2019 Mar; 10(1):1177. PubMed ID: 30862812
[TBL] [Abstract][Full Text] [Related]
7. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
VandenBerg KE; Ahn S; Visick JE
Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
[TBL] [Abstract][Full Text] [Related]
8. MazF-induced growth inhibition and persister generation in Escherichia coli.
Tripathi A; Dewan PC; Siddique SA; Varadarajan R
J Biol Chem; 2014 Feb; 289(7):4191-205. PubMed ID: 24375411
[TBL] [Abstract][Full Text] [Related]
9. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin.
Bernier SP; Lebeaux D; DeFrancesco AS; Valomon A; Soubigou G; Coppée JY; Ghigo JM; Beloin C
PLoS Genet; 2013; 9(1):e1003144. PubMed ID: 23300476
[TBL] [Abstract][Full Text] [Related]
10. MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth.
Cho J; Carr AN; Whitworth L; Johnson B; Wilson KS
Microbiology (Reading); 2017 Mar; 163(3):308-321. PubMed ID: 28113053
[TBL] [Abstract][Full Text] [Related]
11. Persister Heterogeneity Arising from a Single Metabolic Stress.
Amato SM; Brynildsen MP
Curr Biol; 2015 Aug; 25(16):2090-8. PubMed ID: 26255847
[TBL] [Abstract][Full Text] [Related]
12. Metabolic control of persister formation in Escherichia coli.
Amato SM; Orman MA; Brynildsen MP
Mol Cell; 2013 May; 50(4):475-87. PubMed ID: 23665232
[TBL] [Abstract][Full Text] [Related]
13. Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances.
Tang J; Herzfeld AM; Leon G; Brynildsen MP
mBio; 2024 May; 15(5):e0037424. PubMed ID: 38564687
[TBL] [Abstract][Full Text] [Related]
14. Role of oxidative stress in persister tolerance.
Wu Y; Vulić M; Keren I; Lewis K
Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
[TBL] [Abstract][Full Text] [Related]
15. Fragmentation of Escherichia coli mRNA by MazF and MqsR.
Mets T; Kasvandik S; Saarma M; Maiväli Ü; Tenson T; Kaldalu N
Biochimie; 2019 Jan; 156():79-91. PubMed ID: 30315853
[TBL] [Abstract][Full Text] [Related]
16.
Mohiuddin SG; Massahi A; Orman MA
mBio; 2022 Feb; 13(1):e0218721. PubMed ID: 35038905
[TBL] [Abstract][Full Text] [Related]
17. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
[TBL] [Abstract][Full Text] [Related]
18. The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment.
Byrd BA; Zenick B; Rocha-Granados MC; Englander HE; Hare PJ; LaGree TJ; DeMarco AM; Mok WWK
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0028121. PubMed ID: 34097492
[TBL] [Abstract][Full Text] [Related]
19. Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathway.
Erental A; Sharon I; Engelberg-Kulka H
PLoS Biol; 2012; 10(3):e1001281. PubMed ID: 22412352
[TBL] [Abstract][Full Text] [Related]
20. The SOS response is permitted in Escherichia coli strains deficient in the expression of the mazEF pathway.
Kalderon Z; Kumar S; Engelberg-Kulka H
PLoS One; 2014; 9(12):e114380. PubMed ID: 25470502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
